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Because invasion is, either directly or via metastasis 
formation, the main cause of death in cancer patients, the 
development of efficient anti-invasive agents forms an 
important research challenge in medicinal chemistry. In 
the quest for potent lead compounds, a large group of 
plant polyphenolics and alkaloids were screened in vitro 
for their anti-invasive activity.1,2 
 
The assay was based on organotypic confronting cultures 
between human MCF-7/6 invasive mammary cancer cells 
and a fragment of precultured normal heart tissue (PHF) 
from 9-days old chick embryos. Anti-invasive activity 
was observed at concentrations as low as 1µmol/l for 
several flavonoids, 5 of which contained the 1,3-
diphenylpropenone (chalcone) skeleton. Furthermore, a 
large number of chalcones possessed good activity at 
higher concentrations.3 
 
 
  
 
Figure 1: Illustration of the chick heart invasion assay. 
Panel A shows the invasion of untreated cultures by the 
carcinoma cells after 8 days of incubation, while in panel 
B invasion was inhibited by addition of an anti-invasive 
agent to the culture medium. 
 
 
As such, a dataset of 68 differentially functionalized 
chalcones with various activity levels was obtained, and 
used to establish two-dimensional quantitative structure-
activity relationships (2D-QSAR). Using the best 
multilinear regression method of CODESSA Pro, a 
statistically satisfactory correlation between the lowest 
active concentration and 6 molecular descriptors was 
obtained. 
 
The model is now used to predict the anti-invasive 
activity of hypothetical compounds in silico, thus solely 
based on their molecular structure. This way, synthetic 
efforts can be focussed on promising targets. Meanwhile, 
preparation and derivatisation protocols for chalcones and 
related polyphenolics will be optimized, enabling the 
synthesis of compounds with a high potential activity. 
 
In this context, a mild, high yielding preparation of 
chalcones via a LiOH catalyzed Claisen-Schmidt 
condensation was developed, and substituent and reaction 
temperature effects were studied (Scheme 1). Several 
demethylation techniques were evaluated on the thus 
prepared methoxychalcones. Selective demethylation on 
the A-ring of methoxychalcones can be achieved by 
treatment with thiophenolate and is explained by 
comparison of the Hammett constants of the methoxy 
groups on the two rings. Still, C-prenylated chalcones 
were prepared via a Florisil catalyzed [1,3]-shift of their 
intermediately generated O-prenylated analogues. 
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Scheme 1: Synthesis of functionalized chalcones. 
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